Skip to main content
Close

Breast

Protocols

BRAJAC

Adjuvant Therapy for Breast Cancer Using DOXOrubicin and Cyclophosphamide


BRAJACT

Adjuvant Therapy for Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by PACLitaxel


BRAJACTG

Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel


BRAJACTT

Adjuvant Therapy for Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab


BRAJACTTG

Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab


BRAJACTW

Adjuvant Therapy for Early Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by Weekly PACLitaxel


BRAJANAS

Neoadjuvant or Adjuvant Therapy for Breast Cancer using Anastrozole in Postmenopausal Women


BRAJCAFG 

Adjuvant Therapy for Breast Cancer Using Cyclophosphamide, DOXOrubicin , Fluorouracil and Filgrastim (G-CSF) (Deleted 01 May 2015)


BRAJCAFPO

AdjuvantTherapy for Breast Cancer Using Oral Cyclophosphamide, DOXOrubicin and Fluorouracil (Deleted 01 May 2015​)


BRAJCEFG

Adjuvant Therapy for Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF)


BRAJCMF

Adjuvant Therapy for High Risk Breast Cancer Using Cyclophosphamide (IV), Methotrexate and Fluorouracil


BRAJCMFPO

Adjuvant Therapy for High-Risk Breast Cancer Using Cyclophosphamide (oral), Methotrexate and Fluorouracil


UBRAJDAC

Adjuvant Therapy for Breast Cancer Using Cyclophosphamide, DOXOrubicin and DOCEtaxel


BRAJDC

Adjuvant Therapy for Breast Cancer Using DOCEtaxel and Cyclophosphamide


BRAJDCARBT

AdjuvantTherapy for Breast Cancer Using DOCEtaxel, CARBOplatin, and Trastuzumab


BRAJDTFEC

Adjuvant Therapy for Breast Cancer Using DOCEtaxel and Trastuzumab, and Fluorouracil, Epirubicin and Cyclophosphamide


BRAJEXE

Neoadjuvant or Adjuvant Therapy for Breast Cancer using Exemestane in Postmenopausal Women

BRAJFEC

Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide


BRAJFECD 

AdjuvantTherapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide and DOCEtaxel


BRAJFECDT

AdjuvantTherapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab


BRAJLET

Neoadjuvant or Adjuvant Therapy for Breast Cancer using Letrozole in Postmenopausal Women


UBRAJLHRHA

Neoadjuvant or Adjuvant Therapy for Breast Cancer Using a LHRH Agonist and an Aromatase Inhibitor (Replaced by BRAJLHRHAI)


BRAJLHRHAI
Adjuvant Ovarian Suppression and Aromatase Inhibitor in Premenopausal Women with High Risk Early Stage Breast Cancer

BRAJLHRHT
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using a LHRH Agonist and Tamoxifen

BRAJTAM

Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Tamoxifen

BRAJTDC

Adjuvant Therapy for Breast Cancer Using Trastuzumab, DOCEtaxel and Cyclophosphamide


BRAJTR

Adjuvant Therapy for Breast Cancer Using Trastuzumab following the Completion of Chemotherapy (Sequential)

Locally Advanced 

BRLAACD

Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel


BRLAACDT

Treatmentof Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab


BRLAACTW

Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by Weekly PACLitaxel (REPLACED BY BRLATWAC)


UBRLA2

Therapy for Locally Advanced Breast Cancer Using Cyclophosphamide, DOXOrubicin and Fluorouracil


UBRLACEF

Therapy for Locally Advanced Breast Cancer Using Cyclophosphamide, Epirubicin and Fluorouracil


BRLACEFG

Therapy for Locally Advanced Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF)


BRLATACG

NEOAdjuvant Therapy for Breast Cancer Using Dose Dense Therapy: PACLitaxel Followed by DOXOrubicin and Cyclophosphamide


BRLATWAC

NEOAdjuvant Therapy for Locally Advanced Breast Cancer Using Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide

Advanced 

BRAVA7

Palliative Therapy for Metastatic Breast Cancer Using Weekly DOXOrubicin


BRAVAC

Palliative Therapy for Metastatic Breast Cancer Using DOXOrubicin and Cyclophosphamide


BRAVABR

Palliative Therapy for Metastatic Breast Cancer Using nanoparticle, albumin-bound (nab)-PACLitaxel (ABRAXANE®)


BRAVANAS

Palliative Therapy for Metastatic Breast Cancer Using Anastrozole


BRAVCAF

Palliative Therapy for Metastatic Breast Cancer Using Cyclophosphamide, DOXOrubicin and Fluorouracil


BRAVCAP

Therapy for Metastatic Breast Cancer Using Capecitabine


BRAVCLOD

For Therapy of Bone Metastases in Breast Cancer Using Oral Clodronate


BRAVCMF

Palliative Therapy for Advanced Breast Cancer Using Cyclophosphamide, Methotrexate and Fluorouracil


BRAVCMFPO

 PalliativeTherapy for Advanced Breast Cancer Using Cyclophosphamide (oral), Methotrexate and Fluorouracil


BRAVCMPO 

Palliative Therapy for Metastatic Breast Cancer Using Metronomic Low-Dose Oral Cyclophosphamide and Methotrexate


BRAVDCAP

Palliative Therapy for Metastatic Breast Cancer Using DOCEtaxel and Capecitabine


BRAVDOC

Palliative Therapy for Metastatic Breast Cancer Using DOCEtaxel


BRAVDOC7 

PalliativeTherapy for Metastatic Breast Cancer Using Weekly Docetaxel


UBRAVERIB 

Palliative Therapy for Metastatic Breast Cancer Using eriBULin


BRAVEVEX 

Therapy for Advanced Breast Cancer Using Everolimus and Exemestane


BRAVEXE

Palliative Therapy for Advanced Breast Cancer Using Exemestane


BRAVGEM 

Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine


BRAVGEMD

PalliativeTherapy for Metastatic Breast Cancer Using Gemcitabine and DOCEtaxel


BRAVGEMP

PalliativeTherapy for Metastatic Breast Cancer Using CISplatin and Gemcitabine


BRAVGEMT

Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine and PACLitaxel


UBRAVKAD

Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab Emtansine


UBRAVLCAP

Therapy for Metastatic Breast Cancer Using Capecitabine and Lapatinib


BRAVLET

Palliative Therapy for Advanced Breast Cancer Using Letrozole


BRAVLHRHA

Therapy for Advanced Breast Cancer Using a LHRH Agonist and an Aromatase Inhibitor

BRAVLHRHT

Palliative Therapy for Breast Cancer Using a LHRH agonist and tamoxifen


BRAVMEG

Palliative Therapy for Advanced Breast Cancer Using Megestrol


BRAVNAV

Palliative Therapy for Symptomatic Metastatic Breast Cancer Using Vinorelbine


BRAVPAM

Treatment of Acute Bone Pain Secondary to Breast Cancer Metastases Using Pamidronate


BRAVPTRAD 

Palliative Therapy for Metastatic Breast Cancer Using Pertuzumab, Trastuzumab, and DOCEtaxel as First-Line Treatment for Advanced Breast Cancer


BRAVT7

Palliative Therapy for Metastatic Breast Cancer Using Weekly PACLitaxel (REPLACED BY BRAVTW Dec 2014)


BRAVTAM 

Palliative Therapy for Breast Cancer Using Tamoxifen


BRAVTAX

Palliative Therapy for Metastatic Breast Cancer Using PACLitaxel


UBRAVTCAP

Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab and Capecitabine


BRAVTEST

Palliative Therapy for Metastatic Breast Cancer Using Testosterone Enanthate


BRAVTPCARB

Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab, PACLitaxel and CARBOplatin as First-Line Treatment for Advanced Breast Cancer


BRAVTR

Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab


BRAVTRAD 

PalliativeTherapy for Metastatic Breast Cancer Using Trastuzumab and DOCEtaxel as First-Line Treatment for Advanced Breast Cancer


BRAVTRAP

PalliativeTherapy for Metastatic Breast Cancer Using Trastuzumab and PACLitaxel as First-Line Treatment for Advanced Breast Cancer


BRAVTRVIN

PalliativeTherapy for Metastatic Breast Cancer Using Trastuzumab and Vinorelbine


BRAVTW

Palliative Therapy for Metastatic Breast Cancer Using Weekly PACLitaxel (3 Weeks Out of 4 Weeks Schedule)


BRINFCAF

Therapy for Inflammatory Breast Cancer Using Cyclophosphamide, DOXOrubicin and Fluorouracil  (Deleted 01 May 2015)


BRINFCEF

Therapy for Inflammatory Breast Cancer Using Cyclophosphamide, Epirubicin and Fluorouracil


BRINFCEFG

Therapy for Inflammatory Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF).

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use.

Tab Heading
Tab Heading
SOURCE: Breast ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer Agency. All Rights Reserved.

    Copyright © 2016 Provincial Health Services Authority.